Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy
Conditions
- Cholangiocarcinoma of the Gallbladder
- Localized Gallbladder Cancer
- Unresectable Gallbladder Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: everolimus
- DRUG: gemcitabine hydrochloride
- DRUG: cisplatin
Sponsor
Mayo Clinic
Collaborators